Interpretation of management guidelines for preventing exposure to antineoplastics
10.3760/cma.j.cn114015-20230302-00142
- VernacularTitle:《抗肿瘤药物暴露防护管理指南》解读
- Author:
Wei LIU
1
;
Ziyang WU
;
Guanhua DU
;
Baohua LI
;
Liyan MIAO
;
Haiqing SONG
;
Yuqin WANG
;
Kehu YANG
;
Xianglin ZHANG
;
Yanhua ZHANG
;
Yu ZHANG
;
Zhu ZHU
;
Jun ZHU
;
Suodi ZHAI
Author Information
1. 北京大学第三医院药剂科,北京大学医学部药物评价中心,北京 100191
- Publication Type:Journal Article
- Keywords:
Antineoplastics;
Exposure prevention;
Guideline;
Interpretation
- From:
Adverse Drug Reactions Journal
2023;25(3):133-137
- CountryChina
- Language:Chinese
-
Abstract:
Exposure to antineoplastics is a potential health threat. If improperly disposed, it will also cause environmental pollution, which is a medical safety issue worthy of attention. In order to improve the protection awareness of healthcare professionals exposed to antineoplastic drugs (medical personnels, drug transportation staffs, patients and their caregivers, etc.), standardize exposure protection operations, and reduce the risk and harm of occupational exposure, the Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society, the Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, the Oncology Society of Chinese Medical Association, the Nursing Branch of China International Exchange and Promotive Association for Medical and Healthcare, and Chinese Pharmacological Society Professional Committee of Drug-induced Diseases formulated the Management guidelines for preventing exposure to antineoplastics, which was published in the 1st issue of Chinese Journal of Cancer Research in 2023. The guideline was developed referring to the World Health Organization handbook for guideline development and other international methodologies and focused on the full-process management of antineoplastics in hospitals. Using the Delphi method, clinical questions and 14 recommendations were formulated. This paper interprets 14 recommendations, hoping to help promote the implementation of the guideline.